Each year, thousands of patients in the United States wait for a liver transplant, while transplant teams must make rapid, ...

Reimbursement uncertainty and absent permanent billing codes remain dominant CGT access barriers, exposing limitations of “buy-and-bill” models and necessitating dedicated staffing and early ...

Trained Scientists, Biotech Startup Advances Predictive AI to Improve Human Safety Assessment, Reduce Costly Drug Attrition and Accelerate Drug Development BOSTON, MA / ACCESS Newswire / July 7, 2026 ...

Founded by MIT-Trained Scientists, Biotech Startup Advances Predictive AI to Improve Human Safety Assessment, Reduce Costly ...

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of ...

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to predict which patients with a primary ...

Researchers @hopkinskimmel and @HopkinsMed develop methods to predict which #livercancer patients do best with combination ...

GemPharmatech, an international provider of in vivo efficacy testing and genetically engineered animal models, and Humlab Global, a Singapore-based developer of humanized mouse models and ...

A new study challenges a 60-year-old assumption about the body’s main structural building block, opening new possibilities ...

A groundbreaking study from IIT Bombay reveals a new cellular mechanism that reduces harmful blood lipids while preventing fat buildup in the liver, paving the way for innovative treatments for ...

VivoSim Labs, Inc. (Nasdaq: VIVS) (the 'Company” or 'VivoSim”), a provider of next-generation New Approach Methodologies (NAM) 3d human cellular models for preclinical safety, today announced revenue ...

The presence of chronic kidney disease, heart failure, or cirrhosis is linked to increased odds of inpatient death and ...